Participants
Disorders and Stroke-Alzheimer Disease, psychotic or mood disorders, alcoholism, seizure, stroke, metabolic diseases, depressive disorder, schizophrenia, diabetes
FOLIC ACID DEFICIENCY, DISORDERS, CHRONIC RENAL FAILURE, STROKE, HEPATIC FAILURE, METABOLIC DISEASES, HYPERTHYROIDISM, DIABETES
We registered the data of 52 patients at Myongji Hospital in Goyang, Republic of Korea, and Cheongpungho Geriatric Hospital from September to December 2021. All patients underwent a detailed medical history taking, neurological examinations, neuroimaging (brain computed tomography or magnetic resonance imaging), and blood and neuropsychological tests, and met the criteria of probable AD according to the National Institute of Neurological and Communicative Disorders and Stroke-Alzheimer Disease and Related Disorders Association (NINCDS-ADRDA) (The exclusion criteria were the presence of metabolic diseases that could affect cognitive function (hyperthyroidism, vitamin B12 or folic acid deficiency, chronic renal failure, uncontrolled diabetes, and hepatic failure), chronic alcoholism, and a history of stroke, seizure, and brain surgery. Furthermore, patients who met the Diagnostic and Statistical Manual of Mental Disorders (Fifth edition) for psychotic or mood disorders such as schizophrenia or major depressive disorder were also excluded (